Blackstone has announced the closing of its newest life sciences private fund.
The fund — Blackstone Life Sciences VI — was oversubscribed and closed at its hard cap of $6.3 billion in commitments.
Blackstone (NYSE: BX), founded in 1985 and based in New York, is one of the largest global alternative asset managers. Blackstone Life Sciences (BXLS) is a private investment platform with capabilities to invest across the life cycle of companies and products within life science sectors.